ALPINE IMMUNE SCIENCES, INC. Net Change in Cash
ALPINE IMMUNE SCIENCES, INC. reported Net Change in Cash of -$10.90 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-05-09
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$10.90M, a 1101.38% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $1.09M.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$33.02M.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$22.33M, a 368.29% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $30.56M.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$54.53M, a 265.51% decline from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $32.95M, a 76.15% increase from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $18.70M, a 230.11% increase from fiscal 2019.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$10.90M 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $30.56M 10-K · filed 2024-03-20 | |||
| 2023-09-30 | $5.61M 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $20.70M 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $1.09M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$54.53M 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $58.72M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$43.55M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$33.02M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $32.95M 10-K · filed 2024-03-20 | |||
| 2021-09-30 | $41.14M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$16.15M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$22.33M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $18.70M 10-K · filed 2023-03-23 | |||
| 2020-09-30 | $124.82M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $71.97M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | $8.32M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $5.67M 10-K · filed 2022-03-17 | |||
| 2019-09-30 | $6.94M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $5.01M 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | $30.98M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $2.71M 10-K · filed 2021-03-18 | |||
| 2018-09-30 | $3.47M 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | -$4.43M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$554.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$3.69M 10-K · filed 2020-03-30 | |||
| 2017-09-30 | $295.00K 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $19.42M 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $1.75M 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $6.40M 10-K · filed 2019-03-18 | |||
| 2016-09-30 | $8.53M 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $5.42M 10-K · filed 2018-03-28 |